Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3)
 
  				This Funding Opportunity Announcement (FOA) is an initiative to support the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays that are clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs.  Funds will be made available through the UH2/UH3 phased innovation cooperative agreement award mechanism. Applicants should have a working assay or prototype (not necessarily already capable of cancer applications). The initial UH2 exploratory phase will be a feasibility study to demonstrate technical functionality and clinical potential for use in LMIC settings by meeting specific performance milestones. UH2 projects that have met their milestones will be administratively considered by NCI and NIBIB and subsequently prioritized for transition to the UH3 validation phase. UH3 awards will support improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed and therefore all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must address both UH2 and UH3 phases.
					General information about this opportunity
					
					Last Known Status
				 
					Deleted 04/06/2015 (Archived.)
					Program Number
				 
					RFA-CA-15-001					
Federal Agency/Office
				 
					Agency: Department of Health and Human Services
Office: National Institutes of Health					
Type(s) of Assistance Offered
				 
					Cooperative Agreement					
Number of Awards Available
					6					
Who is eligible to apply/benefit from this assistance?
					Applicant Eligibility
					Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.					
What is the process for applying and being award this assistance?
					Deadlines
					03/06/2015					
Other Assistance Considerations
					Formula and Matching Requirements
					This program does not have cost sharing or matching requirements.					
Who do I contact about this opportunity?
					Headquarters Office
					NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV					
Website Address
					http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-001.html
					E-mail Address
					FBOWebmaster@OD.NIH.GOV
					Financial Information
					Obligations
					$3,000,000.00					
Range and Average of Financial Assistance
					Awards up to $1,000,000.00